Celanese Announces Contemplated Closure of Two European Manufacturing Facilities
Mon, November 4 2013
Employee consultation process to begin at Roussillon,
Celanese announced on
Therefore, today the company regretfully announces its intent to
initiate discussions concerning the possible closure of both the acetic
anhydride facility in Roussillon and the VAM production unit in
The need for these contemplated projects emerged from an assessment of Celanese’s overall corporate strategy, which included an assessment of the company’s global manufacturing facilities. Specifically, in support of the company’s acetyl portfolio, the manufacturing footprint strategy favors integrated production sites that provide critical economies of scale.
Celanese subsidiaries that operate these facilities expect to soon begin the consultation process with local employee representatives to mitigate the social impact of these contemplated closures to the best possible extent.
About Celanese
All registered trademarks are owned by
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, and other information that
is not historical information. When used in this release, the
words “estimates,” “expects,” “anticipates,” “projects,” “plans,”
“intends,” “believes,” and variations of such words or similar
expressions are intended to identify forward-looking statements. All
forward-looking statements are based upon current expectations and
beliefs and various assumptions. There can be no assurance that
the company will realize these expectations or that these beliefs will
prove correct. There are a number of risks and uncertainties that
could cause actual results to differ materially from the forward-looking
statements contained in this release. Numerous factors, many of
which are beyond the company’s control, could cause actual results to
differ materially from those expressed as forward-looking statements.
Other risk factors include those that are discussed in the company’s
filings with the
Investor Relations
Jon.Puckett@celanese.com
or
Media
–
William.Jacobsen@celanese.com
Media
–
J.Kurth@celanese.com
Source: